TCL Archive NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions October 16, 2009
TCL Archive CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP December 1, 1989
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
